Global Percutaneous Surgical Robot Market Growth 2025-2031

The global Percutaneous Surgical Robot market size is predicted to grow from US$ 947 million in 2025 to US$ 2463 million in 2031; it is expected to grow at a CAGR of 17.3% from 2025 to 2031.

The percutaneous puncture robot is a robot that locates the target anatomy through MRI, ultrasound, CT and other imaging technologies, guides the feedback needle to reach the target anatomical structure, and assists in the completion of percutaneous puncture surgery. Its current uses mainly include detection of early lung cancer, breast cancer, and prostate cancer and corresponding treatment. The puncture surgical robots currently on the market mainly include ANT from NDR, MAXIO from Perfint Healthcare, iSR’obot from Biobot Surgical, Tuodao Medical and Guangdong Truehealth, etc.

LP Information, Inc. (LPI) ' newest research report, the “Percutaneous Surgical Robot Industry Forecast” looks at past sales and reviews total world Percutaneous Surgical Robot sales in 2024, providing a comprehensive analysis by region and market sector of projected Percutaneous Surgical Robot sales for 2025 through 2031. With Percutaneous Surgical Robot sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Surgical Robot industry.

This Insight Report provides a comprehensive analysis of the global Percutaneous Surgical Robot landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Surgical Robot portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Percutaneous Surgical Robot market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Surgical Robot and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Surgical Robot.

This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Surgical Robot market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Puncture Examination
Puncture Treatment

Segmentation by Application:
Hospital
Diagnostic Center

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Biobot Surgical
Tuodao Medical
HANS Robot
Guangdong Truehealth
XACT Robotics
Perfint Healthcare
NDR

Key Questions Addressed in this Report

What is the 10-year outlook for the global Percutaneous Surgical Robot market?

What factors are driving Percutaneous Surgical Robot market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Percutaneous Surgical Robot market opportunities vary by end market size?

How does Percutaneous Surgical Robot break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.